Abstract
Systemic infections caused by fungi that a serious health risk and these have been increasing in recent decades, they are raising mortality and morbidity of the patients. Among these yeast, the Candida albicans accounts for 50%-70% of infections. Studies demonstrate, the appearance of resistant strains to the main antifungal agents in the treatment of candidiasis. New antifungal molecules…